Levamisole [levamisol]
- Terms
-
Decaris
L-tetramisol
levamisol hydrochlorid
Nilverm
-
Decaris
Dekaris
L-Tetramisole
Levamisole Hydrochloride
Levotetramisole
Solaskil
An antihelminthic drug that has been tried experimentally in rheumatic disorders where it apparently restores the immune response by increasing macrophage chemotaxis and T-lymphocyte function. Paradoxically, this immune enhancement appears to be beneficial in rheumatoid arthritis where dermatitis, leukopenia, and thrombocytopenia, and nausea and vomiting have been reported as side effects. (From Smith and Reynard, Textbook of Pharmacology, 1991, p435-6)
- DUI
- D007978 MeSH Browser
- CUI
- M0012431
- CAS
- Imidazo(2,1-b)thiazole, 2,3,5,6-tetrahydro-6-phenyl-, (S)-
- History note
- 74
- Public note
- 74
Allowable subheadings
- AD
- administration & dosage 19
- AE
- adverse effects 6
- AG
- agonists
- AA
- analogs & derivatives 3
- AN
- analysis 2
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry 2
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology 2
- IP
- isolation & purification 1
- ME
- metabolism 1
- PK
- pharmacokinetics
- PD
- pharmacology 10
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 54
- TO
- toxicity
- UR
- urine